These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 10490833

  • 1. The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation.
    Belka C, Marini P, Lepple-Wienhues A, Budach W, Jekle A, Los M, Lang F, Schulze-Osthoff K, Gulbins E, Bamberg M.
    Oncogene; 1999 Sep 02; 18(35):4983-92. PubMed ID: 10490833
    [Abstract] [Full Text] [Related]

  • 2. The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathways.
    Belka C, Gruber C, Jendrossek V, Wesselborg S, Budach W.
    Oncogene; 2003 Jan 16; 22(2):176-85. PubMed ID: 12527887
    [Abstract] [Full Text] [Related]

  • 3. Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis.
    Belka C, Rudner J, Wesselborg S, Stepczynska A, Marini P, Lepple-Wienhues A, Faltin H, Bamberg M, Budach W, Schulze-Osthoff K.
    Oncogene; 2000 Feb 24; 19(9):1181-90. PubMed ID: 10713706
    [Abstract] [Full Text] [Related]

  • 4. Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells.
    Gong B, Almasan A.
    Cancer Res; 2000 Oct 15; 60(20):5754-60. PubMed ID: 11059770
    [Abstract] [Full Text] [Related]

  • 5. Involvement of tyrosine kinase p56/Lck in apoptosis induction by anticancer drugs.
    Gruber C, Henkel M, Budach W, Belka C, Jendrossek V.
    Biochem Pharmacol; 2004 May 15; 67(10):1859-72. PubMed ID: 15130763
    [Abstract] [Full Text] [Related]

  • 6. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis.
    Engels IH, Stepczynska A, Stroh C, Lauber K, Berg C, Schwenzer R, Wajant H, Jänicke RU, Porter AG, Belka C, Gregor M, Schulze-Osthoff K, Wesselborg S.
    Oncogene; 2000 Sep 21; 19(40):4563-73. PubMed ID: 11030145
    [Abstract] [Full Text] [Related]

  • 7. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors.
    Gil J, Esteban M.
    Oncogene; 2000 Jul 27; 19(32):3665-74. PubMed ID: 10951573
    [Abstract] [Full Text] [Related]

  • 8. The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis.
    Chen CY, Juo P, Liou JS, Li CQ, Yu Q, Blenis J, Faller DV.
    Cell Growth Differ; 2001 Jun 27; 12(6):297-306. PubMed ID: 11432804
    [Abstract] [Full Text] [Related]

  • 9. The tyrosine kinase Lck is a positive regulator of the mitochondrial apoptosis pathway by controlling Bak expression.
    Samraj AK, Stroh C, Fischer U, Schulze-Osthoff K.
    Oncogene; 2006 Jan 12; 25(2):186-97. PubMed ID: 16116473
    [Abstract] [Full Text] [Related]

  • 10. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
    Fulda S, Meyer E, Friesen C, Susin SA, Kroemer G, Debatin KM.
    Oncogene; 2001 Mar 01; 20(9):1063-75. PubMed ID: 11314043
    [Abstract] [Full Text] [Related]

  • 11. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Chatterjee D, Schmitz I, Krueger A, Yeung K, Kirchhoff S, Krammer PH, Peter ME, Wyche JH, Pantazis P.
    Cancer Res; 2001 Oct 01; 61(19):7148-54. PubMed ID: 11585748
    [Abstract] [Full Text] [Related]

  • 12. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
    Dirsch VM, Stuppner H, Vollmar AM.
    Cancer Res; 2001 Aug 01; 61(15):5817-23. PubMed ID: 11479221
    [Abstract] [Full Text] [Related]

  • 13. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S, Meyer E, Debatin KM.
    Cancer Res; 2000 Jul 15; 60(14):3947-56. PubMed ID: 10919673
    [Abstract] [Full Text] [Related]

  • 14. Ionizing radiation utilizes c-Jun N-terminal kinase for amplification of mitochondrial apoptotic cell death in human cervical cancer cells.
    Kim MJ, Lee KH, Lee SJ.
    FEBS J; 2008 May 15; 275(9):2096-108. PubMed ID: 18373696
    [Abstract] [Full Text] [Related]

  • 15. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly.
    Holmström TH, Schmitz I, Söderström TS, Poukkula M, Johnson VL, Chow SC, Krammer PH, Eriksson JE.
    EMBO J; 2000 Oct 16; 19(20):5418-28. PubMed ID: 11032809
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein.
    Grassi F, Piacentini A, Cristino S, Toneguzzi S, Facchini A, Lisignoli G.
    Arthritis Rheum; 2004 Feb 16; 50(2):498-506. PubMed ID: 14872492
    [Abstract] [Full Text] [Related]

  • 17. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG, Phan VA, Phan VH, Celli A, Batts K, LaRusso NF, Gores GJ.
    Hepatology; 1999 Dec 16; 30(6):1398-404. PubMed ID: 10573518
    [Abstract] [Full Text] [Related]

  • 18. Activation of caspase-8 during N-(4-hydroxyphenyl)retinamide-induced apoptosis in Fas-defective hepatoma cells.
    You KR, Shin MN, Park RK, Lee SO, Kim DG.
    Hepatology; 2001 Dec 16; 34(6):1119-27. PubMed ID: 11732001
    [Abstract] [Full Text] [Related]

  • 19. Activation of caspases and cleavage of Bid are required for tyrosine and phenylalanine deficiency-induced apoptosis of human A375 melanoma cells.
    Ge X, Fu YM, Li YQ, Meadows GG.
    Arch Biochem Biophys; 2002 Jul 01; 403(1):50-8. PubMed ID: 12061801
    [Abstract] [Full Text] [Related]

  • 20. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
    Amanullah A, Liebermann DA, Hoffman B.
    Oncogene; 2002 Feb 28; 21(10):1600-10. PubMed ID: 11896589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.